Financhill
Sell
33

UNH Quote, Financials, Valuation and Earnings

Last price:
$470.99
Seasonality move :
7.05%
Day range:
$438.50 - $469.70
52-week range:
$436.38 - $630.73
Dividend yield:
1.75%
P/E ratio:
30.09x
P/S ratio:
1.08x
P/B ratio:
4.37x
Volume:
19.5M
Avg. volume:
4.9M
1-year change:
-10.64%
Market cap:
$429.2B
Revenue:
$400.3B
EPS (TTM):
$15.50

Analysts' Opinion

  • Consensus Rating
    UnitedHealth Group has received a consensus rating of Buy. The company's average rating is a Buy based on 20 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $637.24, UnitedHealth Group has an estimated upside of 36.62% from its current price of $466.42.
  • Price Target Downside
    According to analysts, the lowest downside price target is $590.00 representing -- downside risk from its current price of $466.42.

Fair Value

  • According to the consensus of 21 analysts, UnitedHealth Group has 36.62% upside to fair value with a price target of $637.24 per share.

UNH vs. S&P 500

  • Over the past 5 trading days, UnitedHealth Group has overperformed the S&P 500 by 2.69% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • UnitedHealth Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • UnitedHealth Group has grown year-over-year revenues for 141 quarters straight. In the most recent quarter UnitedHealth Group reported revenues of $100.8B.

Earnings Growth

  • UnitedHealth Group has grown year-over-year earnings for 2 quarters straight. In the most recent quarter UnitedHealth Group reported earnings per share of $5.98.
Enterprise value:
481.4B
EV / Invested capital:
0.00x
Price / LTM sales:
1.08x
EV / EBIT:
20.08x
EV / Revenue:
1.20x
PEG ratio (5yr expected):
--
EV / Free cash flow:
23.25x
Price / Operating cash flow:
20.88x
Enterprise value / EBITDA:
17.14x
Gross Profit (TTM):
$89.4B
Return On Assets:
5%
Net Income Margin (TTM):
3.6%
Return On Equity:
14.34%
Return On Invested Capital:
8.3%
Operating Margin:
7.71%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $324.2B $371.6B $400.3B $94.4B $100.8B
Gross Profit $79.6B $91B $89.4B $22B $21.3B
Operating Income $28.4B $32.4B $32.3B $7.7B $7.8B
EBITDA $31.8B $36.3B $28.1B $8.7B $8.8B
Diluted EPS $21.19 $23.84 $15.50 $5.83 $5.98
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $53.7B $61.8B $69.1B $78.4B $85.8B
Total Assets $197.3B $212.2B $245.7B $273.7B $298.3B
Current Liabilities $72.4B $78.3B $89.2B $99.1B $103.8B
Total Liabilities $126.8B $135.7B $159.4B $174.8B $195.7B
Total Equity $70.5B $76.5B $86.3B $98.9B $102.6B
Total Debt $43.5B $46B $57.6B $62.5B $76.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $26.2B $29.1B $24.2B -$5.2B $2.4B
Cash From Investing -$28.5B -$15.6B -$20.5B -$1.2B -$1.1B
Cash From Financing $4.2B -$11.5B -$3.5B -$7.2B -$8.3B
Free Cash Flow $23.4B $25.7B $20.7B -$6.2B $1.5B
UNH
Sector
Market Cap
$429.2B
$43.6M
Price % of 52-Week High
--
47.57%
Dividend Yield
1.75%
0%
Shareholder Yield
2.97%
-0.67%
1-Year Price Total Return
-10.64%
-34.6%
Beta (5-Year)
0.615
0.747
Dividend yield:
1.75%
Annualized payout:
$8.18
Payout ratio:
52.29%
Growth streak:
15 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $512.08
200-day SMA
Sell
Level $546.98
Bollinger Bands (100)
Sell
Level 516.67 - 591.69
Chaikin Money Flow
Buy
Level 339M
20-day SMA
Sell
Level $528.26
Relative Strength Index (RSI14)
Sell
Level 27.71
ADX Line
Sell
Level 23.71
Williams %R
Neutral
Level -75.808
50-day SMA
Sell
Level $521.90
MACD (12, 26)
Sell
Level -9.48
25-day Aroon Oscillator
Sell
Level -52
On Balance Volume
Neutral
Level 486.8M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8021)
Sell
CA Score (Annual)
Level (-0.3316)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.5916)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 51 million members globally, including 1 million outside the us as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Stock Forecast FAQ

In the current month, UNH has received 20 Buy ratings 1 Hold ratings, and 0 Sell ratings. The UNH average analyst price target in the past 3 months is $637.24.

  • Where Will UnitedHealth Group Stock Be In 1 Year?

    According to analysts, the consensus estimate is that UnitedHealth Group share price will rise to $637.24 per share over the next 12 months.

  • What Do Analysts Say About UnitedHealth Group?

    Analysts are divided on their view about UnitedHealth Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UnitedHealth Group is a Sell and believe this share price will drop from its current level to $590.00.

  • What Is UnitedHealth Group's Price Target?

    The price target for UnitedHealth Group over the next 1-year time period is forecast to be $637.24 according to 21 Wall Street analysts, 20 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is UNH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for UnitedHealth Group is a Buy. 20 of 21 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of UNH?

    You can purchase shares of UnitedHealth Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UnitedHealth Group shares.

  • What Is The UnitedHealth Group Share Price Today?

    UnitedHealth Group was last trading at $470.99 per share. This represents the most recent stock quote for UnitedHealth Group. Yesterday, UnitedHealth Group closed at $466.42 per share.

  • How To Buy UnitedHealth Group Stock Online?

    In order to purchase UnitedHealth Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Palantir Stock Split?
Will Palantir Stock Split?

Shares of Palantir Technologies (NASDAQ:PLTR) have skyrocketed over the last…

Why Is Philippe Laffont Buying TSM?
Why Is Philippe Laffont Buying TSM?

With a personal net worth of approximately $6.5 billion and…

Is Abbott Labs Stock a Buy, Sell or Hold?
Is Abbott Labs Stock a Buy, Sell or Hold?

The degree to which the healthcare paradigm has changed is…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Sell
2
GLOB alert for Feb 25

Globant SA [GLOB] is up 2.83% over the past day.

Buy
60
HIMS alert for Feb 25

Hims & Hers Health [HIMS] is down 19.28% over the past day.

Buy
70
VICR alert for Feb 25

Vicor [VICR] is down 5.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock